Activity and receptor selectivity of misoprostol, sulprostone and 9-hydroxy variants at cloned human EP3 and EP1 receptors.

被引：0
|
作者：
Soper, D [1 ]
Brann, M [1 ]
Amburgey, J [1 ]
Miley, C [1 ]
Wos, J [1 ]
Wang, Y [1 ]
Hartke, J [1 ]
De, B [1 ]
deLong, M [1 ]
机构：
[1] Procter & Gamble Co, Pharmaceut, Cincinnati, OH 45253 USA
来源：
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY | 1998年 / 215卷
关键词：
D O I：
暂无
中图分类号：
O6 [化学];
学科分类号：
0703 ;
摘要：
050A-MEDI
引用
收藏
页码：U923 / U923
页数：1
相关论文
共 50 条
  • [31] Induction of Orphan Nuclear Receptor Nurr1 Expression by the Human EP1 Prostanoid Receptors
    Ji, Ruyue
    Chen, Xiaobo
    Regan, John W.
    FASEB JOURNAL, 2008, 22
  • [32] Prostaglandin E2 potentiates the immunologically stimulated histamine release from human peripheral blood-derived mast cells through EP1/EP3 receptors
    Wang, XS
    Lau, HYA
    ALLERGY, 2006, 61 (04) : 503 - 506
  • [33] The EP1/EP3 receptor agonist 17-pt-PGE2 acts as an EP4 receptor agonist on endothelial barrier function and in a model of LPS-induced pulmonary inflammation
    Theiler, Anna
    Konya, Viktoria
    Pasterk, Lisa
    Maric, Jovana
    Baernthaler, Thomas
    Lanz, Ilse
    Platzer, Wolfgang
    Schuligoi, Rufina
    Heinemann, Akos
    VASCULAR PHARMACOLOGY, 2016, 87 : 180 - 189
  • [34] Exogenous but not endogenous prostanoids regulate cytokine secretion from murine bone marrow dendritic cells:: EP2, DP, and IP but not EP1, EP3, and FP prostanoid receptors are involved
    Józefowski, S
    Bobek, M
    Marcinkiewicz, J
    INTERNATIONAL IMMUNOPHARMACOLOGY, 2003, 3 (06) : 865 - 878
  • [35] Structure-activity relationship of cinnamic acylsulfonamide analogues on the human EP3 prostanoid receptor
    Juteau, HN
    Gareau, Y
    Labelle, M
    Sturino, CF
    Sawyer, N
    Tremblay, N
    Lamontagne, S
    Carrière, MC
    Denis, D
    Metters, KM
    BIOORGANIC & MEDICINAL CHEMISTRY, 2001, 9 (08) : 1977 - 1984
  • [36] Structure-activity relationship of biaryl acylsulfonamide analogues on the human EP3 prostanoid receptor
    Gallant, M
    Carrière, MC
    Chateauneuf, A
    Denis, D
    Gareau, Y
    Godbout, C
    Greig, G
    Juteau, H
    Lachance, N
    Lacombe, P
    Lamontagne, S
    Metters, KM
    Rochette, C
    Ruel, R
    Slipetz, D
    Sawyer, N
    Tremblay, N
    Labelle, M
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2002, 12 (18) : 2583 - 2586
  • [37] Vasoconstriction induced by activation of EP1 and EP3 receptors in human lung:: effects of ONO-AE-248, ONO-DI-004, ONO-8711 or ONO-8713
    Norel, X
    de Montpreville, V
    Brink, C
    PROSTAGLANDINS & OTHER LIPID MEDIATORS, 2004, 74 (1-4) : 101 - 112
  • [38] Regulation of the human prostanoid TPα and TPβ receptor isoforms mediated through activation of the EP1 and IP receptors
    Walsh, MT
    Kinsella, BT
    BRITISH JOURNAL OF PHARMACOLOGY, 2000, 131 (03) : 601 - 609
  • [39] Anorexia and cachexia in prostaglandin EP1 and EP3 subtype receptor knockout mice bearing a tumor with high intrinsic PGE2 production and prostaglandin related cachexia
    Wang, W
    Andersson, M
    Lönnroth, C
    Svanberg, E
    Lundholm, K
    JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH, 2005, 24 (01): : 99 - 107
  • [40] Up-regulation of EP2 and EP3 receptors in human tolerogenic dendritic cells boosts the immunosuppressive activity of PGE2
    Florez-Grau, Georgina
    Cabezon, Raquel
    Borgman, Kyra J. E.
    Espana, Carolina
    Jose Lozano, Juan
    Garcia-Parajo, Maria F.
    Benitez-Ribas, Daniel
    JOURNAL OF LEUKOCYTE BIOLOGY, 2017, 102 (03) : 881 - 895
12345